UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Development and Validation of the Pediatric Hypersomnolence Survey

Neurology, 2022-05, Vol.98 (19), p.e1964

2022

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

Neurology, 2017-01, Vol.88 (2), p.152

2017

Volltextzugriff (PDF)

In vivo staging of regional amyloid deposition

Neurology, 2017-11, Vol.89 (20), p.2031

2017

Volltextzugriff (PDF)

Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline

Neurology, 2017-11, Vol.89 (21), p.2176

2017

Volltextzugriff (PDF)

MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults

Neurology, 2012-01, Vol.78 (2), p.84

2012

Volltextzugriff (PDF)

Type 2 diabetes mellitus, brain atrophy, and cognitive decline

Neurology, 2019-02, Vol.92 (8), p.e823

2019

Volltextzugriff (PDF)

Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals

Neurology, 2023-01, Vol.100 (3), p.e275

2023

Volltextzugriff (PDF)

Polygenic risk of Alzheimer disease is associated with early- and late-life processes

Neurology, 2016-08, Vol.87 (5), p.481

2016

Volltextzugriff (PDF)

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy

Neurology, 2016-04, Vol.86 (15), p.1368

2016

Volltextzugriff (PDF)

APOE genotype and early β-amyloid accumulation in older adults without dementia

Neurology, 2017-09, Vol.89 (10), p.1028

2017

Volltextzugriff (PDF)

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

Neurology, 2016-04, Vol.86 (15), p.1377

2016

Volltextzugriff (PDF)

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

Neurology, 2015-02, Vol.84 (5), p.508

2015

Volltextzugriff (PDF)

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

Neurology, 2011-10, Vol.77 (15), p.1473

2011

Volltextzugriff (PDF)

Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease

Neurology, 2020-09, Vol.95 (10), p.e1301

2020

Volltextzugriff (PDF)

Predicting MCI outcome with clinically available MRI and CSF biomarkers

Neurology, 2011-10, Vol.77 (17), p.1619

2011

Volltextzugriff (PDF)

Periventricular hyperintensities are associated with elevated cerebral amyloid

Neurology, 2016-02, Vol.86 (6), p.535

2016

Volltextzugriff (PDF)

Vascular burden and Alzheimer disease pathologic progression

Neurology, 2012-09, Vol.79 (13), p.1349

2012

Volltextzugriff (PDF)

Large-scale replication and heterogeneity in Parkinson disease genetic loci

Neurology, 2012-08, Vol.79 (7), p.659

2012

Volltextzugriff (PDF)

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load

Neurology, 2017-02, Vol.88 (6), p.569

2017

Volltextzugriff (PDF)

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

Neurology, 2016-05, Vol.86 (20), p.1887

2016

Volltextzugriff (PDF)

Alzheimer disease biomarkers are associated with body mass index

Neurology, 2011-11, Vol.77 (21), p.1913

2011

Volltextzugriff (PDF)

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Neurology, 2015-10, Vol.85 (15), p.1283

2015

Volltextzugriff (PDF)

Brain structure and function as mediators of the effects of amyloid on memory

Neurology, 2015-03, Vol.84 (11), p.1136

2015

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTechnical Communication

KollektionIngentaConnect Journals

Zeitschrift / SerieNeurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Clinical Neurology
(27)
Humans
(27)
Life Sciences & Biomedicine
(27)
Neurosciences & Neurology
(27)
Science & Technology
(27)
Female
(22)
Male
(22)
Aged
(20)
Aged, 80 And Over
(12)
Neurology
(11)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(9)
Magnetic Resonance Imaging
(9)
Middle Aged
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Disease Progression
(7)
Longitudinal Studies
(7)
Positron-Emission Tomography
(7)
Alzheimer Disease - Diagnostic Imaging
(6)
Alzheimer Disease - Pathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Neurology. Clinical Practice
(1)

Menü

Weitere Dienste

Einstellungen

Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Development and Validation of the Pediatric Hypersomnolence Survey

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

In vivo staging of regional amyloid deposition

Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline

MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults

Type 2 diabetes mellitus, brain atrophy, and cognitive decline

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals

Polygenic risk of Alzheimer disease is associated with early- and late-life processes

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy

APOE genotype and early β-amyloid accumulation in older adults without dementia

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease

Predicting MCI outcome with clinically available MRI and CSF biomarkers

Periventricular hyperintensities are associated with elevated cerebral amyloid

Vascular burden and Alzheimer disease pathologic progression

Large-scale replication and heterogeneity in Parkinson disease genetic loci

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

Alzheimer disease biomarkers are associated with body mass index

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Brain structure and function as mediators of the effects of amyloid on memory

Aktive Filter

Suchergebnisse filtern